This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
S$7.44
Share price
-0.34%
Change (1 day)
1.70%
Change (1 year)
Categories
KemPharm (KMPH) - Total debt
Total debt on the balance sheet as of December 2022 : S$29.58 Million
According to KemPharm's latest financial reports the company's total debt is S$29.58 Million. A company’s total debt is the sum of all current and non-current debts.
KemPharm - Total debt on balance sheet (from 2014 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | S$30.99 M | 1324.71% |
| 2021-12-31 | S$2.17 M | -97.67% |
| 2020-12-31 | S$93.32 M | -12.95% |
| 2019-12-31 | S$0.10 B | -4.35% |
| 2018-12-31 | S$0.11 B | -10.35% |
| 2017-12-31 | S$0.12 B | -5.41% |
| 2016-12-31 | S$0.13 B | 304.53% |
| 2015-12-31 | S$32.67 M | 36.27% |
| 2014-12-31 | S$23.97 M | 376.69% |
| 2013-12-31 | S$5.02 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | S$6.93 B | 23,344.65% | 🇮🇪 Ireland |
 Agile Therapeutics
AGRX | S$0.36 M | -98.75% | 🇺🇸 USA |
 Theravance Biopharma
TBPH | S$61.63 M | 108.31% | Cayman Islands |
 ANI Pharmaceuticals ANIP | S$0.79 B | 2,594.22% | 🇺🇸 USA |